LncRNA | Tumor suppressor | Oncogene | CSC properties |
|---|
AK139328 | − | + | N/D |
BANCR | − | + | + |
CASC2 | + | − | N/D |
FOXD2-AS1 | − | + | + |
GAS5 | + | − | N/D |
H19 | − | + | N/D |
HCP5 | − | + | N/D |
HOTAIR | + | − | + |
HOTAIRM1 | − | + | N/D |
KLHL14-AS | + | − | N/D |
Linc00210 | − | + | N/D |
LINC00312 | + | − | N/D |
LOC100507661 | − | + | N/D |
MALAT1 | − | + | + |
MANCR | − | + | + |
MIR22HG | + | − | N/D |
NEAT1 | − | + | N/D |
PAR5 | + | − | + |
PCA3 | − | + | N/D |
PTCSC3 | + | − | + |
PVT1 | − | + | + |
ROR | − | + | + |
SNHG15 | + | − | N/D |
SNHG7 | − | + | N/D |
TNRC6C-AS1 | − | + | N/D |
TUG1 | − | + | + |
UCA1 | − | + | N/D |
XIST | − | + | N/D |
ZFAS1 | − | + | N/D |
- N/D, not detected; BANCR, BRAF-activated non-protein coding RNA; CASC2, cancer susceptibility candidate 2; CSC, cancer stem cell; FOXD2-AS1, FOXD2 adjacent opposite strand RNA 1; GAS5, growth arrest special 5; HCP5, HLA complex P5; HOTAIR, HOX transcript antisense RNA; HOTAIRM1, hox antisense intergenic RNA myeloid 1; Klhl14, kelch like family member 14; Linc00210, long intergenic non-protein coding RNA 210; LINC00312, long intergenic non-protein coding RNA 312; LncRNA, long noncoding RNA, MALAT1: metastasis-associated lung adenocarcinoma transcript 1; MANCR, mitotically associated long non coding RNA; MIR22HG, MIR22 host gene; NEAT1, nuclear paraspeckle assembly transcript 1; PAR5, Prader Wili/Angelman region RNA 5; PCA3, prostate cancer antigen 3; PTCSC3, papillary thyroid carcinoma susceptibility candidate 3; PVT1, plasmacytoma variant translocation 1; ROR, regulator of reprogramming; SNHG15, small nucleolar RNA host gene 15; SNHG7, small nucleolar RNA host gene 7; TNRC6C-AS1, TNRC6C antisense RNA 1; TUG1, taurine up-regulated gene 1;UCA1, urothelial carcinoma-associated 1; XIST, X inactive specific transcript; ZFAS1, ZNFX1 antisense RNA 1
